Eisai
4523.T
#2117
Rank
โ‚น822.92 B
Marketcap
โ‚น2,919
Share price
-0.10%
Change (1 day)
28.98%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น80.29. an increase over its 2024 EPS that were of โ‚น90.51.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น101.2411.85%
2024โ‚น90.51-32.63%
2023โ‚น134.355.52%
2022โ‚น127.32-74.01%
2021โ‚น489.83-66.58%
2020โ‚น1,46598.24%
2019โ‚น739.2417.01%
2018โ‚น631.7637.78%
2017โ‚น458.54-27.62%
2016โ‚น633.5435.33%
2015โ‚น468.14-2.82%
2014โ‚น481.74-27.66%
2013โ‚น665.98-27.49%
2012โ‚น918.51-12.67%
2011โ‚น1,05288.08%
2010โ‚น559.24-11.06%
2009โ‚น628.80-390.15%
2008-โ‚น216.72-127.78%
2007โ‚น780.2211.78%
2006โ‚น698.014.38%
2005โ‚น668.757.4%
2004โ‚น622.7043.03%
2003โ‚น435.3825.09%
2002โ‚น348.0452.67%
2001โ‚น227.9669.76%
2000โ‚น134.29